Warner Says Mylan Misstatements Key To Doryx Antitrust Row
Warner Chilcott and Mayne Pharma have pressed the Third Circuit to let them file an extra brief opposing Mylan's attempt to revive antitrust claims over the acne medication Doryx, arguing that...To view the full article, register now.
Already a subscriber? Click here to view full article